This article is more than 5 years old. Information may no longer be current.

FDA requests investment in foodborne illness prevention, product safety measures

Issue: March 2011

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

As part of President Barack Obama’s fiscal year 2012 budget, the FDA is requesting $4.3 billion to protect and promote the public health — a 33% increase from the 2010 FDA-enacted budget.

Four critical initiatives have been proposed for the 2012 budget:

• Transforming Food Safety and Nutrition Initiative ($324 million): FDA will begin to implement the Food Safety Modernization Act and also empower Americans to make healthier food choices.
• Advancing Medical Countermeasures Initiative ($70 million): This increase will ensure that FDA can support the development of medical countermeasures to respond to serious national security threats — chemical, biological, radiological and nuclear threats, as well as naturally emerging diseases such as pandemic influenza.
• Protecting Patients Initiative ($124 million): FDA will develop a pathway for approving biological drugs shown to be highly similar to, and without clinically meaningful differences with, an FDA-approved reference biological product.
• Regulatory Science and Facilities Initiative ($49 million): This request will allow FDA to strengthen its core regulatory scientific capacity that supports all elements of the FDA mission.

“FDA protects and promotes the health of all Americans through every stage of life,” Margaret A. Hamburg, MD, commissioner of the FDA, said in a press release. “The breadth of this mandate means that FDA responsibilities continue to grow. The new budget contains new resources so that FDA can fulfill its growing responsibilities to the American public.”

For more information, visit www.hhs.gov/budget/.

Follow InfectiousDiseaseNews.com on Twitter.